Table IV.
No. | Species | AN | Interpretation* | CLA after 5 days of incubation | Interpretation* | CLA after 14 days of incubation | Interpretation* |
---|---|---|---|---|---|---|---|
1 | Mabs | 16 | (S) | 0.06 | (S) | 0,5 | (S) |
2 | Mabs | 8 | (S) | 0.06 | (S) | > 64 | (R) |
3 | Mabs | 16 | (S) | 0.06 | (S) | = 32 | (R) |
4 | Mabs | 16 | (S) | 0.06 | (S) | = 32 | (R) |
5 | Mabs | 16 | (S) | 0.06 | (S) | = 32 | (R) |
6 | Mabs | 16 | (S) | 0.06 | (S) | = 32 | (R) |
7 | Mmas | – | – | – | – | – | – |
8 | Mmas | 16 | (S) | 0.06 | (S) | = 0.125 | (S) |
9 | Mabs | 16 | (S) | 0.06 | (S) | = 0.125 | (S) |
10 | Mmas | 16 | (S) | 0.06 | (S) | = 0.06 | (S) |
11 | Mbol | 0.5 | (S) | 0.06 | (S) | > 64 | (R) |
12 | Mabs | 0.250 | (S) | 4 | (R) | = 16 | (R) |
Mabs – Mycobacterium abscessus subsp. Abscessus, Mmas – Mycobacterium abscessus subsp. massiliense, Mbol – Mycobacterium abscessus subsp. bolletii
S – susceptible, I – intermediate, R – resistant
AN – amikacin, CLA – clarithromycin
* – interpretation of the result was done according CLSI